Anpath Group, Inc. Stock Other OTC
Equities
US03634J3041
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 21.71M |
---|---|---|---|---|---|
Net income 2022 | -5M | Net income 2023 | -4M | EV / Sales 2022 | - |
Net Debt 2022 | 226K | Net cash position 2023 | 1.38M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.23
x | P/E ratio 2023 |
-3.6
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 47.64% |
Managers | Title | Age | Since |
---|---|---|---|
Douglas Baum
FOU | Founder | 57 | 04-08-25 |
Founder | 54 | 04-08-25 | |
Adam King
DFI | Director of Finance/CFO | 39 | 21-12-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Piazza
FOU | Founder | 77 | 04-08-25 |
Founder | 54 | 04-08-25 | |
Charles Link
BRD | Director/Board Member | 64 | 21-02-14 |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |